Mizuho Sees Heron Therapeutics' (HRTX) HTX-011 Receiving Approval with Broad Label In Mid-2019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. SPY
6. MU
7. HTZ
8. KBH
9. HON
10. JPM

Go back to Mizuho Sees Heron Therapeutics' (HRTX) HTX-011 Receiving Approval with Broad Label In Mid-2019

Heron Therapeutics (HRTX) Prices $200M Common Share Offering

June 26, 2018 5:39 AM EDT

Heron Therapeutics, Inc. (NASDAQ: HRTX) today announced the pricing of an underwritten public offering of approximately $200 million of shares of its common stock. In addition, Heron has granted the underwriter of the offering a 30-day option to purchase up to an additional approximately $30 million of... More